Vannfrie aripiprazol-krystaller D, fremgangsmåte for fremstilling derav, samt farmasøytisk preparat

The present invention provides an improved low hygroscopic form, form E, of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the aripiprazole anhydride crystals is stored for an e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YAMADA SHOHEI, TOMINAGA MICHIAKI, TAKAHASHI MASANORI, AOKI SATOSHI, FUJIMOTO KIYOSHI, SHINHAMA KOICHI, NISHIOKA YOSHIHIRO, NAKAGAWA TOMONORI, KAWASAKI JUNICHI, TOMIKAWA KENJI, FUJIMURA TSUTOMO, ISHIGAMI MAKOTO, ABE KAORU, TANIGUCHI YOUICHI, KOBAYASHI NORIYUKI, YABUUCHI TSUYOSHI, BANDO TAKUJI, UTSUMI NAOTO, OI YOSHIHIRO
Format:	Patent
Sprache:	nor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PERFORMING OPERATIONS PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SEPARATION SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TRANSPORTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides an improved low hygroscopic form, form E, of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the aripiprazole anhydride crystals is stored for an extended period.